查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1404638

基因组学市场规模、份额、趋势分析报告：按应用/技术、按可交付成果、按最终用途、按地区、细分市场预测，2024-2030 年

Genomics Market Size, Share & Trends Analysis Report By Application & Technology (Functional Genomics, Epigenomics), By Deliverable (Products, Services), By End-use (Clinical Research, Hospital & Clinics), By Region, & Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 200 Pages | 商品交期: 2-10个工作天内

价格

基因组学市场成长与趋势：

Grand View Research, Inc. 的最新报告显示，到 2030 年，全球基因组学市场预计将达到 948.6 亿美元。

由于基因组学中对新型治疗和研究应用的需求不断增加，预计该市场在预测期内的复合年增长率将达到 16.5%。此外，基因组学具有广泛的应用，包括药物基因组学和宏基因组学。基因组学的新应用由产业合作伙伴关係和业务扩张推动。例如，2020年6月，Merck & Co., Inc.和10x Genomics, Inc.宣布，透过使用10x Genomics的条码技术，用CRISPR文库筛检单细胞，合作开发强大的基于基因组学的实验，以更好地了解细胞之间的关係。癌症和疾病。

基因组学市场的技术进步，例如染色体不稳定性和基因特征的研究，透过利用庞大资料库中的独特样本，提供了对潜在临床应用的全面洞察。例如，2022 年 6 月，剑桥大学和国家癌症研究中心（西班牙马德里）的研究人员追踪了染色体不稳定性和拷贝数变化，以确定此类基因组是否能够推理出内部因素在促进变化中的作用。

由遗传引起的疾病可引起多种疾病，包括心血管疾病、糖尿病和癌症。透过了解个体基因组序列的特定特征可以有效对抗遗传疾病。例如，2021年11月，Illumina, Inc.和Genetic Alliance联合宣布推出iHope遗传健康计划，为世界各地的遗传病倖存者序列测定，我决定这样做。

政府和其他研究机构对基因组定序相关研究进展的积极支持推动了市场的积极发展。人们越来越关注资助基因组主导研究中资料驱动的倡议，以推动有助于治疗罕见疾病、感染疾病、遗传性疾病和癌症的结果。例如，2022 年 8 月，医疗设备创新联盟启动了体细胞参考样本倡议，以开发临床相关样本和公共基因资料集，以帮助加强基于 NGS 的癌症诊断。同样，2022 年9 月，美国疾病管制中心(CDC) 宣布了一项为期五年的倡议，旨在建立病原体基因组卓越中心(PGCoE) 网络，以促进生物资讯学、病原体基因组学和分子流行病学方面的创新和能力。的奖项。

预计影响基因组学市场的最重要因素之一是医学界在个人化医疗中利用现有基因组资讯的程度和程度。此外，定序成本的直线下降也推动了全基因测序的采用。科学家正在将定序产生的资料与诊断相结合，事实证明这可以有效增强个体化治疗。根据 OGL 发布的报告，截至 2021 年 7 月，英国已进行了超过 60 万次 SARS-CoV-2 基因组定序测试。基因组定序透过快速识别相关变异、了解它们的传播方式并阻止它们，有助于对抗 SARS-CoV-2。

基因组市场报告亮点

  • 整个基因组学市场的成长是由于人们越来越依赖基于基因组学的对遗传疾病和癌症新疗法的理解。
  • 由于诊断和基因治疗应用的需求不断增加，功能基因组学将在 2023 年占据最大的市场占有率。由于生物标记在疾病和治疗研究中的应用不断增加，预计生物标记发现将成为预测期内成长最快的领域。
  • 由于主要参与者的存在以及政府和研究机构对促进该地区基因组研究的日益支持，北美在 2023 年占据了市场主导地位。

目录

第一章调查方法和范围

第 2 章执行摘要

第三章市场变数、趋势和范围

  • 市场区隔和范围
  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场抑制因素分析
  • 产业分析工具
    • SWOT 分析；按因素（政治/法律、经济/技术）
    • 波特五力分析
  • COVID-19感染疾病的影响分析

第四章基因组学市场：应用与技术业务分析

  • 基因组学市场：应用和技术的市场占有率分析
  • 按应用和技术
  • 功能基因体学
  • 表观基因
  • 途径分析
  • 生物标记发现
  • 其他的

第五章基因组学市场：可交付成果业务分析

  • 基因组学市场：可交付成果市场占有率分析
  • 按可交付成果
  • 产品
  • 服务

第六章 基因组学市场：最终用途业务分析

  • 基因组学市场：最终用途市场占有率分析
  • 按最终用途
  • 临床调查
  • 学术和政府机构
  • 医院和诊所
  • 製药和生物技术公司
  • 其他的

第七章 基因组市场：区域业务分析

  • 2022 年和 2030 年按地区市场占有率
  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东/非洲

第八章竞争形势

  • 财务绩效
  • 参与企业
    • 市场领导者
  • 参与企业概况
    • Agilent Technologies
    • Bio-Rad Laboratories, Inc
    • BGI Genomics
    • Color Genomics, Inc
    • Danaher Corporation
    • Eppendorf AG
    • Eurofins Scientific
    • F. Hoffmann-La Roche Ltd.
    • GE Healthcare
    • Illumina, Inc.
    • Myriad Genetics, Inc
    • Oxford Nanopore Technologies
    • Pacific Biosciences of California, Inc
    • QIAGEN NV
    • Quest Diagnostics Incorporated
    • Thermo Fisher Scientific, Inc
    • 23andMe, Inc
  • 策略规划
    • 扩张
    • 获得
    • 合作
    • 产品/服务发布
    • 合伙
    • 其他的
Product Code: 978-1-68038-188-7

Genomics Market Growth & Trends:

The global genomics market size is expected to reach USD 94.86 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to register a CAGR of 16.5% in the forecast period owing to the increasing demand for novel therapeutic and research applications in genomics. Moreover, it is extensively used for a wide variety of applications, such as pharmacogenomics, and metagenomics. The emerging applications of genomics are braced up by industrial collaborations and expansions. For instance, in June 2020, Merck & Co., Inc., and 10x Genomics, Inc., collaborates to develop powerful genomics-based experiments to better understand the relationship between specific genes and disease by using 10x Genomics' barcode technology to screen single cells using CRISPR libraries.

Technological advancements in the genomics market such as research on chromosomal instability and gene signatures utilizing unique samples from huge databases give out comprehensive insights into their clinical applicability. For instance, in June 2022, researchers from Cambridge University and the National Cancer Research Center (at Madrid, Spain) deduced to track chromosomal instability and copy number variations to understand the role of internal factors in driving such genomic alterations in cancers that are fatal in nature.

Diseases caused by genetic inheritance can cause a wide range of disease conditions such as cardiovascular, diabetes, and cancer conditions. Genetic disorders can be effectively combatted by understanding specific characteristics of an individual's genome sequence. For instance, in November 2021, Illumina, Inc. and the Genetic Alliance, collectively declared the launch of the iHope genetic health program so as to facilitate access to whole-genome sequencing to survivors of genetic disorders across the globeDee with one-third of the efforts to support subjects in Africa.

The market is positively driven by the lucrative support from the government and other research organizations for advancement in research on the genome sequence. There has been an increasing focus on funds for data-driven initiatives on genome sequence research to derive outcomes that are helpful for the treatment of rare diseases, infectious diseases, inherited disorders, and cancers. For instance, in August 2022, Medical Device Innovation Consortium launched its somatic reference samples initiative to develop clinically relevant samples and public genomic datasets to aid the enhancement of NGS-based cancer diagnostics. Similarly, in September 2022, the Centres for Disease Control (CDC) declared 5-year awards to establish the pathogen genomics centers of excellence (PGCoE) network to foster innovation and capabilities in bioinformatics, pathogen genomics, and molecular epidemiology.

One of the most important factors anticipated to impact the genomics market is how much and to what extent the medical community will make use of available genomic information in personalized medicine. Furthermore, plummeting costs of sequencing support an increase in the adoption of whole genome sequencing. Scientists are combining the data generated from sequencing with diagnostics, which has proven effective in enhancing the personalized treatment landscape. According to a report published by OGL, as of July 2021, the UK exceeded 600,000 SARS-CoV-2 genomically sequenced tests. Genomic sequencing has been helpful in the fight against SARS-CoV-2 by quickly identifying variations that are of concern, elucidating how they spread, and halting them.

Genomics Market Report Highlights:

  • The overall growth of the genomics market is attributed to the rising dependence of novel therapeutics for genetic disorders and cancers on genomics-based understanding
  • Functional genomics held the largest market share in the year 2023, owing to the demand for rising applications in diagnostics and gene therapy. Biomarker discovery is anticipated to be the fastest-growing segment in the forecast period due to rising applications of biomarkers in disease and therapeutics research
  • North America dominated the market in 2023 due to the presence of key players and rising support from the government and research institutes to advance the research on Genomics in the region

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
    • 1.2.1. Application & Technology
    • 1.2.2. Deliverables
    • 1.2.3. End use
  • 1.3. Information analysis
  • 1.4. Market formulation & data visualization
  • 1.5. Data validation & publishing
  • 1.6. Information Procurement
    • 1.6.1. Primary Research
  • 1.7. Information or Data Analysis
  • 1.8. Market Formulation & Validation
  • 1.9. Market Model
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Segmentation and Scope
  • 3.2. Market Lineage Outlook
    • 3.2.1. Parent Market Outlook
    • 3.2.2. Related/Ancillary Market Outlook
  • 3.3. Market Dynamics
    • 3.3.1. Market Driver Analysis
      • 3.3.1.1. Growing integration of genomics data into clinical workflows
      • 3.3.1.1.1. More targeted and personalized healthcare
      • 3.3.1.1.2. Growth of newborn genetic screening programs
      • 3.3.1.1.3. Advancements in noninvasive cancer screening
      • 3.3.1.1.4. Military genomics
      • 3.3.1.2. Technological advances to facilitate genomic R&D
      • 3.3.1.2.1. Emergence of advanced genome editing techniques
      • 3.3.1.2.2. Integration of new data streams
      • 3.3.1.2.3. RNA biology
      • 3.3.1.2.4. Single-cell biology
      • 3.3.1.3. Rising adoption of DIRECT-TO-CONSUMER genomics
      • 3.3.1.4. Success of genetic tools in agrigenomics
      • 3.3.1.5. Increasing participation of different companies
      • 3.3.1.6. Increase in government role and funding in genomics
    • 3.3.2. Market Restraint Analysis
      • 3.3.2.1. Issues regarding intellectual property protection, data management, and public policies
      • 3.3.2.2. Dearth of Public databases and personnel knowledge on machine learning algorithms
  • 3.4. Industry Analysis Tools
    • 3.4.1. SWOT Analysis; By Factor (Political & Legal, Economic And Technological)
    • 3.4.2. Porter's Five Forces Analysis
  • 3.5. COVID-19 Impact Analysis

Chapter 4. Genomics Market: Application & Technology Business Analysis

  • 4.1. Genomics Market: Application & Technology Market Share Analysis
  • 4.2. Genomics Market Estimates & Forecast, By Application & Technology (USD Million)
  • 4.3. Functional Genomics
    • 4.3.1. Global Functional Genomics Market, 2018 - 2030 (USD Million)
    • 4.3.2. Transfection
      • 4.3.2.1. Global Transfection Market, 2018 - 2030 (USD Million)
    • 4.3.3. Real-Time PCR
      • 4.3.3.1. Global Real-Time PCR Market, 2018 - 2030 (USD Million)
    • 4.3.4. RNA Interference
      • 4.3.4.1. Global RNA Interference Market, 2018 - 2030 (USD Million)
    • 4.3.5. Mutational Analysis
      • 4.3.5.1. Global Mutational Analysis Market, 2018 - 2030 (USD Million)
    • 4.3.6. SNP Analysis
      • 4.3.6.1. Global SNP Analysis Market, 2018 - 2030 (USD Million)
    • 4.3.7. Microarray Analysis
      • 4.3.7.1. Global Microarray Analysis Market, 2018 - 2030 (USD Million)
  • 4.4. Epigenomics
    • 4.4.1. Global Epigenomics Market, 2018 - 2030 (USD Million)
    • 4.4.2. Bisulfite Sequencing
      • 4.4.2.1. Global Bisulfite Sequencing Market, 2018 - 2030 (USD Million)
    • 4.4.3. Chromatin Immunoprecipitation (ChIP & ChIP-Seq)
      • 4.4.3.1. Global Chromatin Immunoprecipitation (ChIP & ChIP-Seq) Market, 2018 - 2030 (USD Million)
    • 4.4.4. Methylated DNA Immunoprecipitation (MeDIP)
      • 4.4.4.1. Global Methylated DNA Immunoprecipitation (MeDIP) Market, 2018 - 2030 (USD Million)
    • 4.4.5. High-Resolution Melt (HRM)
      • 4.4.5.1. Global High-Resolution Melt (HRM) Market, 2018 - 2030 (USD Million)
    • 4.4.6. Chromatin Accessibility Assays
      • 4.4.6.1. Global Chromatin Accessibility Assays Market, 2018 - 2030 (USD Million)
    • 4.4.7. Microarray Analysis
      • 4.4.7.1. Global Microarray Analysis Market, 2018 - 2030 (USD Million)
  • 4.5. Pathway Analysis
    • 4.5.1. Global Pathway Analysis Market, 2018 - 2030 (USD Million)
    • 4.5.2. Bead-Based Analysis
      • 4.5.2.1. Global Bead-Based Analysis Market, 2018 - 2030 (USD Million)
    • 4.5.3. Microarray Analysis
      • 4.5.3.1. Global Microarray Analysis Market, 2018 - 2030 (USD Million)
    • 4.5.4. Real-time PCR
      • 4.5.4.1. Global Real-time PCR Market, 2018 - 2030 (USD Million)
    • 4.5.5. Proteomics Tools (2-D PAGE; yeast 2-hybrid studies)
      • 4.5.5.1. Global Proteomics Tools (2-D PAGE; yeast 2-hybrid studies) Market, 2018 - 2030 (USD Million)
  • 4.6. Biomarker Discovery
    • 4.6.1. Global Biomarker Discovery Market, 2018 - 2030 (USD Million)
    • 4.6.2. Mass Spectrometry
      • 4.6.2.1. Global Mass Spectrometry Market, 2018 - 2030 (USD Million)
    • 4.6.3. Real-time PCR
      • 4.6.3.1. Global Real-time PCR Market, 2018 - 2030 (USD Million)
    • 4.6.4. Microarray Analysis
      • 4.6.4.1. Global Microarray Analysis Market, 2018 - 2030 (USD Million)
    • 4.6.5. Statistical Analysis
      • 4.6.5.1. Global Statistical Analysis Market, 2018 - 2030 (USD Million)
    • 4.6.6. Bioinformatics
      • 4.6.6.1. Global Bioinformatics Market, 2018 - 2030 (USD Million)
    • 4.6.7. DNA Sequencing
      • 4.6.7.1. Global DNA Sequencing Market, 2018 - 2030 (USD Million)
  • 4.7. Others
    • 4.7.1. Global Others Market, 2018 - 2030 (USD Million)

Chapter 5. Genomics Market: Deliverables Business Analysis

  • 5.1. Genomics Market: Deliverables Market Share Analysis
  • 5.2. Genomics Market Estimates & Forecast, By Deliverables (USD Million)
  • 5.3. Products
    • 5.3.1. Global Products Market, 2018 - 2030 (USD Million)
    • 5.3.2. Instruments/Systems/Software
      • 5.3.2.1. Global Instruments/Systems/Software Market, 2018 - 2030 (USD Million)
    • 5.3.3. Consumables & Reagents
      • 5.3.3.1. Global Consumables & Reagents Market, 2018 - 2030 (USD Million)
  • 5.4. Services
    • 5.4.1. Global Services Market, 2018 - 2030 (USD Million)
    • 5.4.2. NGS-based Services
      • 5.4.2.1. Global NGS-based Services Market, 2018 - 2030 (USD Million)
    • 5.4.3. Core Genomics Services
      • 5.4.3.1. Global Core Genomics Services Market, 2018 - 2030 (USD Million)
    • 5.4.4. Biomarker Translation Services
      • 5.4.4.1. Global Biomarker Translation Services Market, 2018 - 2030 (USD Million)
    • 5.4.5. Computational Services
      • 5.4.5.1. Global Computational Services Market, 2018 - 2030 (USD Million)
    • 5.4.6. Others
      • 5.4.6.1. Global Others Market, 2018 - 2030 (USD Million)

Chapter 6. Genomics Market: End-use business Analysis

  • 6.1. Genomics Market: End-use Market Share Analysis
  • 6.2. Genomics Market Estimates & Forecast, By End-use (USD Million)
  • 6.3. Clinical Research
    • 6.3.1. Global Clinical Research Market, 2018 - 2030 (USD Million)
  • 6.4. Academic & Government Institutes
    • 6.4.1. Global Academic & Government Institutes Market, 2018 - 2030 (USD Million)
  • 6.5. Hospitals & Clinics
    • 6.5.1. Global Hospitals & Clinics Market, 2018 - 2030 (USD Million)
  • 6.6. Pharmaceutical & Biotechnology Companies
    • 6.6.1. Global Pharmaceutical & Biotechnology Companies Market, 2018 - 2030 (USD Million)
  • 6.7. Others
    • 6.7.1. Global Others Market, 2018 - 2030 (USD Million)

Chapter 7. Genomics Market: Regional Business Analysis

  • 7.1. Genomics Market Share By Region, 2022 & 2030
  • 7.2. North America
    • 7.2.1. North America Genomics Market, 2018 - 2030 (USD Million)
    • 7.2.2. U.S.
      • 7.2.2.1. Key Country Dynamics
      • 7.2.2.2. Competitive Scenario
      • 7.2.2.3. Regulatory Framework
      • 7.2.2.4. U.S. Genomics Market, 2018 - 2030 (USD Million)
    • 7.2.3. Canada
      • 7.2.3.1. Key Country Dynamics
      • 7.2.3.2. Competitive Scenario
      • 7.2.3.3. Regulatory Framework
      • 7.2.3.4. Canada Genomics Market, 2018 - 2030 (USD Million)
  • 7.3. Europe
    • 7.3.1. Europe Genomics Market, 2018 - 2030 (USD Million)
    • 7.3.2. UK
      • 7.3.2.1. Key Country Dynamics
      • 7.3.2.2. Competitive Scenario
      • 7.3.2.3. Regulatory Framework
      • 7.3.2.4. UK Genomics Market, 2018 - 2030 (USD Million)
    • 7.3.3. Germany
      • 7.3.3.1. Key Country Dynamics
      • 7.3.3.2. Competitive Scenario
      • 7.3.3.3. Regulatory Framework
      • 7.3.3.4. Germany Genomics Market, 2018 - 2030 (USD Million)
    • 7.3.4. France
      • 7.3.4.1. Key Country Dynamics
      • 7.3.4.2. Competitive Scenario
      • 7.3.4.3. Regulatory Framework
      • 7.3.4.4. France Genomics Market, 2018 - 2030 (USD Million)
    • 7.3.5. Italy
      • 7.3.5.1. Key Country Dynamics
      • 7.3.5.2. Competitive Scenario
      • 7.3.5.3. Regulatory Framework
      • 7.3.5.4. Italy Genomics Market, 2018 - 2030 (USD Million)
    • 7.3.6. Spain
      • 7.3.6.1. Key Country Dynamics
      • 7.3.6.2. Competitive Scenario
      • 7.3.6.3. Regulatory Framework
      • 7.3.6.4. Spain Genomics Market, 2018 - 2030 (USD Million)
    • 7.3.7. Denmark
      • 7.3.7.1. Key Country Dynamics
      • 7.3.7.2. Competitive Scenario
      • 7.3.7.3. Regulatory Framework
      • 7.3.7.4. Denmark Genomics Market, 2018 - 2030 (USD Million)
    • 7.3.8. Sweden
      • 7.3.8.1. Key Country Dynamics
      • 7.3.8.2. Competitive Scenario
      • 7.3.8.3. Regulatory Framework
      • 7.3.8.4. Sweden Genomics Market, 2018 - 2030 (USD Million)
    • 7.3.9. Norway
      • 7.3.9.1. Key Country Dynamics
      • 7.3.9.2. Competitive Scenario
      • 7.3.9.3. Regulatory Framework
      • 7.3.9.4. Norway Genomics Market, 2018 - 2030 (USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. Asia Pacific Genomics Market, 2018 - 2030 (USD Million)
    • 7.4.2. Japan
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Competitive Scenario
      • 7.4.2.3. Regulatory Framework
      • 7.4.2.4. Japan Genomics Market, 2018 - 2030 (USD Million)
    • 7.4.3. China
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Competitive Scenario
      • 7.4.3.3. Regulatory Framework
      • 7.4.3.4. China Genomics Market, 2018 - 2030 (USD Million)
    • 7.4.4. India
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Competitive Scenario
      • 7.4.4.3. Regulatory Framework
      • 7.4.4.4. India Genomics Market, 2018 - 2030 (USD Million)
    • 7.4.5. Australia
      • 7.4.5.1. Key Country Dynamics
      • 7.4.5.2. Competitive Scenario
      • 7.4.5.3. Regulatory Framework
      • 7.4.5.4. Australia Genomics Market, 2018 - 2030 (USD Million)
    • 7.4.6. Thailand
      • 7.4.6.1. Key Country Dynamics
      • 7.4.6.2. Competitive Scenario
      • 7.4.6.3. Regulatory Framework
      • 7.4.6.4. Thailand Genomics Market, 2018 - 2030 (USD Million)
    • 7.4.7. South Korea
      • 7.4.7.1. Key Country Dynamics
      • 7.4.7.2. Competitive Scenario
      • 7.4.7.3. Regulatory Framework
      • 7.4.7.4. South Korea Genomics Market, 2018 - 2030 (USD Million)
  • 7.5. Latin America
    • 7.5.1. Latin America Genomics Market, 2018 - 2030 (USD Million)
    • 7.5.2. Brazil
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Competitive Scenario
      • 7.5.2.3. Regulatory Framework
      • 7.5.2.4. Brazil Genomics Market, 2018 - 2030 (USD Million)
    • 7.5.3. Mexico
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Competitive Scenario
      • 7.5.3.3. Regulatory Framework
      • 7.5.3.4. Mexico Genomics Market, 2018 - 2030 (USD Million)
    • 7.5.4. Argentina
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Competitive Scenario
      • 7.5.4.3. Regulatory Framework
      • 7.5.4.4. Argentina Genomics Market, 2018 - 2030 (USD Million)
  • 7.6. MEA
    • 7.6.1. MEA Genomics Market, 2018 - 2030 (USD Million)
    • 7.6.2. South Africa
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Competitive Scenario
      • 7.6.2.3. Regulatory Framework
      • 7.6.2.4. South Africa Genomics Market, 2018 - 2030 (USD Million)
    • 7.6.3. Saudi Arabia
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Competitive Scenario
      • 7.6.3.3. Regulatory Framework
      • 7.6.3.4. Saudi Arabia Genomics Market, 2018 - 2030 (USD Million)
    • 7.6.4. UAE
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Competitive Scenario
      • 7.6.4.3. Regulatory Framework
      • 7.6.4.4. UAE Genomics Market, 2018 - 2030 (USD Million)
    • 7.6.5. Kuwait
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Competitive Scenario
      • 7.6.5.3. Regulatory Framework
      • 7.6.5.4. Kuwait Genomics Market, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Financial Performance
  • 8.2. Participant Categorization
    • 8.2.1. Market Leaders
      • 8.2.1.1. Market share analysis, 2023
  • 8.3. Participant's Overview
    • 8.3.1. Agilent Technologies
      • 8.3.1.1. Overview
      • 8.3.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.3.1.3. Technology Benchmarking
      • 8.3.1.4. Strategic Initiatives
    • 8.3.2. Bio-Rad Laboratories, Inc
      • 8.3.2.1. Overview
      • 8.3.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.3.2.3. Technology Benchmarking
      • 8.3.2.4. Strategic Initiatives
    • 8.3.3. BGI Genomics
      • 8.3.3.1. Overview
      • 8.3.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.3.3.3. Technology Benchmarking
      • 8.3.3.4. Strategic Initiatives
    • 8.3.4. Color Genomics, Inc
      • 8.3.4.1. Overview
      • 8.3.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.3.4.3. Technology Benchmarking
      • 8.3.4.4. Strategic Initiatives
    • 8.3.5. Danaher Corporation
      • 8.3.5.1. Overview
      • 8.3.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.3.5.3. Technology Benchmarking
      • 8.3.5.4. Strategic Initiatives
    • 8.3.6. Eppendorf AG
      • 8.3.6.1. Overview
      • 8.3.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.3.6.3. Technology Benchmarking
      • 8.3.6.4. Strategic Initiatives
    • 8.3.7. Eurofins Scientific
      • 8.3.7.1. Overview
      • 8.3.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.3.7.3. Technology Benchmarking
      • 8.3.7.4. Strategic Initiatives
    • 8.3.8. F. Hoffmann-La Roche Ltd.
      • 8.3.8.1. Overview
      • 8.3.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.3.8.3. Technology Benchmarking
      • 8.3.8.4. Strategic Initiatives
    • 8.3.9. GE Healthcare
      • 8.3.9.1. Overview
      • 8.3.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.3.9.3. Technology Benchmarking
      • 8.3.9.4. Strategic Initiatives
    • 8.3.10. Illumina, Inc.
      • 8.3.10.1. Overview
      • 8.3.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.3.10.3. Technology Benchmarking
      • 8.3.10.4. Strategic Initiatives
    • 8.3.11. Myriad Genetics, Inc
      • 8.3.11.1. Overview
      • 8.3.11.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.3.11.3. Technology Benchmarking
      • 8.3.11.4. Strategic Initiatives
    • 8.3.12. Oxford Nanopore Technologies
      • 8.3.12.1. Overview
      • 8.3.12.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.3.12.3. Technology Benchmarking
      • 8.3.12.4. Strategic Initiatives
    • 8.3.13. Pacific Biosciences of California, Inc
      • 8.3.13.1. Overview
      • 8.3.13.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.3.13.3. Technology Benchmarking
      • 8.3.13.4. Strategic Initiatives
    • 8.3.14. QIAGEN N.V.
      • 8.3.14.1. Overview
      • 8.3.14.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.3.14.3. Technology Benchmarking
      • 8.3.14.4. Strategic Initiatives
    • 8.3.15. Quest Diagnostics Incorporated
      • 8.3.15.1. Overview
      • 8.3.15.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.3.15.3. Technology Benchmarking
      • 8.3.15.4. Strategic Initiatives
    • 8.3.16. Thermo Fisher Scientific, Inc
      • 8.3.16.1. Overview
      • 8.3.16.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.3.16.3. Technology Benchmarking
      • 8.3.16.4. Strategic Initiatives
    • 8.3.17. 23andMe, Inc
      • 8.3.17.1. Overview
      • 8.3.17.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.3.17.3. Technology Benchmarking
      • 8.3.17.4. Strategic Initiatives
  • 8.4. Strategy Mapping
    • 8.4.1. Expansion
    • 8.4.2. Acquisition
    • 8.4.3. Collaborations
    • 8.4.4. Product/service launch
    • 8.4.5. Partnerships
    • 8.4.6. Others

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global genomics market, by technology & application, 2018 - 2030 (USD Million)
  • Table 4 Global genomics market, by deliverables, 2018 - 2030 (USD Million)
  • Table 5 Global genomics market, by End-use, 2018 - 2030 (USD Million)
  • Table 6 Global genomics market, by region, 2018 - 2030 (USD Million)
  • Table 7 North America genomics market, by country, 2018 - 2030 (USD Million)
  • Table 8 North America genomics market, by technology & application, 2018 - 2030 (USD Million)
  • Table 9 North America genomics market, by deliverables, 2018 - 2030 (USD Million)
  • Table 10 North America genomics market, by End-use, 2018 - 2030 (USD Million)
  • Table 11 U.S. genomics market, by technology & application, 2018 - 2030 (USD Million)
  • Table 12 U.S. genomics market, by deliverables, 2018 - 2030 (USD Million)
  • Table 13 U.S. genomics market, by End-use, 2018 - 2030 (USD Million)
  • Table 14 Canada genomics market, by technology & application, 2018 - 2030 (USD Million)
  • Table 15 Canada genomics market, by deliverables, 2018 - 2030 (USD Million)
  • Table 16 Canada genomics market, by End-use, 2018 - 2030 (USD Million)
  • Table 17 Europe genomics market, by country, 2018 - 2030 (USD Million)
  • Table 18 Europe genomics market, by technology & application, 2018 - 2030 (USD Million)
  • Table 19 Europe genomics market, by deliverables, 2018 - 2030 (USD Million)
  • Table 20 Europe genomics market, by End-use, 2018 - 2030 (USD Million)
  • Table 21 UK genomics market, by technology & application, 2018 - 2030 (USD Million)
  • Table 22 UK genomics market, by deliverables, 2018 - 2030 (USD Million)
  • Table 23 UK genomics market, by End-use, 2018 - 2030 (USD Million)
  • Table 24 Germany genomics market, by technology & application, 2018 - 2030 (USD Million)
  • Table 25 Germany genomics market, by deliverables, 2018 - 2030 (USD Million)
  • Table 26 Germany genomics market, by End-use, 2018 - 2030 (USD Million)
  • Table 27 France genomics market, by technology & application, 2018 - 2030 (USD Million)
  • Table 28 France genomics market, by deliverables, 2018 - 2030 (USD Million)
  • Table 29 France genomics market, by End-use, 2018 - 2030 (USD Million)
  • Table 30 Italy genomics market, by technology & application, 2018 - 2030 (USD Million)
  • Table 31 Italy genomics market, by deliverables, 2018 - 2030 (USD Million)
  • Table 32 Italy genomics market, by End-use, 2018 - 2030 (USD Million)
  • Table 33 Spain genomics market, by technology & application, 2018 - 2030 (USD Million)
  • Table 34 Spain genomics market, by deliverables, 2018 - 2030 (USD Million)
  • Table 35 Spain genomics market, by End-use, 2018 - 2030 (USD Million)
  • Table 36 Denmark genomics market, by technology & application, 2018 - 2030 (USD Million)
  • Table 37 Denmark genomics market, by deliverables, 2018 - 2030 (USD Million)
  • Table 38 Denmark genomics market, by End-use, 2018 - 2030 (USD Million)
  • Table 39 Sweden genomics market, by technology & application, 2018 - 2030 (USD Million)
  • Table 40 Sweden genomics market, by deliverables, 2018 - 2030 (USD Million)
  • Table 41 Sweden genomics market, by End-use, 2018 - 2030 (USD Million)
  • Table 42 Norway genomics market, by technology & application, 2018 - 2030 (USD Million)
  • Table 43 Norway genomics market, by deliverables, 2018 - 2030 (USD Million)
  • Table 44 Norway genomics market, by End-use, 2018 - 2030 (USD Million)
  • Table 45 Asia Pacific genomics market, by country, 2018 - 2030 (USD Million)
  • Table 46 Asia Pacific genomics market, by technology & application, 2018 - 2030 (USD Million)
  • Table 47 Asia Pacific genomics market, by deliverables, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific genomics market, by End-use, 2018 - 2030 (USD Million)
  • Table 49 Japan genomics market, by technology & application, 2018 - 2030 (USD Million)
  • Table 50 Japan genomics market, by deliverables, 2018 - 2030 (USD Million)
  • Table 51 Japan genomics market, by End-use, 2018 - 2030 (USD Million)
  • Table 52 China genomics market, by technology & application, 2018 - 2030 (USD Million)
  • Table 53 China genomics market, by deliverables, 2018 - 2030 (USD Million)
  • Table 54 China genomics market, by End-use, 2018 - 2030 (USD Million)
  • Table 55 India genomics market, by technology & application, 2018 - 2030 (USD Million)
  • Table 56 India genomics market, by deliverables, 2018 - 2030 (USD Million)
  • Table 57 India genomics market, by End-use, 2018 - 2030 (USD Million)
  • Table 58 Australia genomics market, by technology & application, 2018 - 2030 (USD Million)
  • Table 59 Australia genomics market, by deliverables, 2018 - 2030 (USD Million)
  • Table 60 Australia genomics market, by End-use, 2018 - 2030 (USD Million)
  • Table 61 Thailand genomics market, by technology & application, 2018 - 2030 (USD Million)
  • Table 62 Thailand genomics market, by deliverables, 2018 - 2030 (USD Million)
  • Table 63 Thailand genomics market, by End-use, 2018 - 2030 (USD Million)
  • Table 64 South Korea genomics market, by technology & application, 2018 - 2030 (USD Million)
  • Table 65 South Korea genomics market, by deliverables, 2018 - 2030 (USD Million)
  • Table 66 South Korea genomics market, by End-use, 2018 - 2030 (USD Million)
  • Table 67 Latin America genomics market, by country, 2018 - 2030 (USD Million)
  • Table 68 Latin America genomics market, by technology & application, 2018 - 2030 (USD Million)
  • Table 69 Latin America genomics market, by deliverables, 2018 - 2030 (USD Million)
  • Table 70 Latin America genomics market, by End-use, 2018 - 2030 (USD Million)
  • Table 71 Brazil genomics market, by technology & application, 2018 - 2030 (USD Million)
  • Table 72 Brazil genomics market, by deliverables, 2018 - 2030 (USD Million)
  • Table 73 Brazil genomics market, by End-use, 2018 - 2030 (USD Million)
  • Table 74 Mexico genomics market, by technology & application, 2018 - 2030 (USD Million)
  • Table 75 Mexico genomics market, by deliverables, 2018 - 2030 (USD Million)
  • Table 76 Mexico genomics market, by End-use, 2018 - 2030 (USD Million)
  • Table 77 Argentina genomics market, by technology & application, 2018 - 2030 (USD Million)
  • Table 78 Argentina genomics market, by deliverables, 2018 - 2030 (USD Million)
  • Table 79 Argentina genomics market, by End-use, 2018 - 2030 (USD Million)
  • Table 80 Middle East & Africa genomics market, by country, 2018 - 2030 (USD Million)
  • Table 81 Middle East & Africa genomics market, by technology & application, 2018 - 2030 (USD Million)
  • Table 82 Middle East & Africa genomics market, by deliverables, 2018 - 2030 (USD Million)
  • Table 83 Middle East & Africa genomics market, by End-use, 2018 - 2030 (USD Million)
  • Table 84 South Africa genomics market, by technology & application, 2018 - 2030 (USD Million)
  • Table 85 South Africa genomics market, by deliverables, 2018 - 2030 (USD Million)
  • Table 86 South Africa genomics market, by End-use, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia genomics market, by technology & application, 2018 - 2030 (USD Million)
  • Table 88 Saudi Arabia genomics market, by deliverables, 2018 - 2030 (USD Million)
  • Table 89 Saudi Arabia genomics market, by End-use, 2018 - 2030 (USD Million)
  • Table 90 UAE genomics market, by technology & application, 2018 - 2030 (USD Million)
  • Table 91 UAE genomics market, by deliverables, 2018 - 2030 (USD Million)
  • Table 92 UAE genomics market, by End-use, 2018 - 2030 (USD Million)
  • Table 93 Kuwait genomics market, by technology & application, 2018 - 2030 (USD Million)
  • Table 94 Kuwait genomics market, by deliverables, 2018 - 2030 (USD Million)
  • Table 95 Kuwait genomics market, by End-use, 2018 - 2030 (USD Million)
  • Table 96 Participant's overview
  • Table 97 Financial performance
  • Table 98 Key companies undergoing expansions
  • Table 99 Key companies undergoing acquisitions
  • Table 100 Key companies undergoing collaborations
  • Table 101 Key companies launching new products/services
  • Table 102 Key companies undertaking other strategies

List of Figures

  • Fig. 1 Genomics market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Market snapshot
  • Fig. 10 Segment snapshot
  • Fig. 11 Competitive landscape snapshot
  • Fig. 12 Parent market outlook
  • Fig. 13 Related/ancillary market outlook
  • Fig. 14 Genomics - Industry value chain analysis
  • Fig. 15 Genomics market driver analysis
  • Fig. 16 Genomics market restraint analysis
  • Fig. 17 Genomics market: Porter's analysis
  • Fig. 18 Genomics market: application & technology outlook and key takeaways
  • Fig. 19 Genomics market: Application & technology market share analysis, 2022 - 2030
  • Fig. 20 Global sequencing by Functional Genomics market, 2018 - 2030 (USD Million)
  • Fig. 21 Global sequencing by Real-time PCR market, 2018 - 2030 (USD Million)
  • Fig. 22 Global sequencing by Transfection market, 2018 - 2030 (USD Million)
  • Fig. 23 Global sequencing by SNP analysis market, 2018 - 2030 (USD Million)
  • Fig. 24 Global sequencing by Mutational analysis market, 2018 - 2030 (USD Million)
  • Fig. 25 Global sequencing by Microarray analysis market, 2018 - 2030 (USD Million)
  • Fig. 26 Global sequencing by RNA interference market, 2018 - 2030 (USD Million)
  • Fig. 27 Global sequencing by Epigenomics market, 2018 - 2030 (USD Million)
  • Fig. 28 Global sequencing by Bisulfite sequencing market, 2018 - 2030 (USD Million)
  • Fig. 29 Global sequencing by Microarray analysis market, 2018 - 2030 (USD Million)
  • Fig. 30 Global sequencing by Chromatin immunoprecipitation (ChIP & ChIP-Seq) market, 2018 - 2030 (USD Million)
  • Fig. 31 Global sequencing by Methylated DNA immunoprecipitation (MeDIP) market, 2018 - 2030 (USD Million)
  • Fig. 32 Global sequencing by High resolution melt (HRM) market, 2018 - 2030 (USD Million)
  • Fig. 33 Global sequencing by Chromatin accessibility assays market, 2018 - 2030 (USD Million)
  • Fig. 34 Global sequencing by Pathway Analysis market, 2018 - 2030 (USD Million)
  • Fig. 35 Global sequencing by Microarray analysis market, 2018 - 2030 (USD Million)
  • Fig. 36 Global sequencing by Bead-based analysis market, 2018 - 2030 (USD Million)
  • Fig. 37 Global sequencing by Proteomics tools (2-D PAGE; yeast 2-hybrid studies) market, 2018 - 2030 (USD Million)
  • Fig. 38 Global sequencing by Real-time PCR market, 2018 - 2030 (USD Million)
  • Fig. 39 Global sequencing by Biomarker Discovery market, 2018 - 2030 (USD Million)
  • Fig. 40 Global sequencing by DNA sequencing market, 2018 - 2030 (USD Million)
  • Fig. 41 Global sequencing by Microarray analysis market, 2018 - 2030 (USD Million)
  • Fig. 42 Global sequencing by Real-time PCR market, 2018 - 2030 (USD Million)
  • Fig. 43 Global sequencing by Mass spectrometry market, 2018 - 2030 (USD Million)
  • Fig. 44 Global sequencing by Statistical analysis market, 2018 - 2030 (USD Million)
  • Fig. 45 Global sequencing by Bioinformatics market, 2018 - 2030 (USD Million)
  • Fig. 46 Global sequencing by Products market, 2018 - 2030 (USD Million)
  • Fig. 47 Global sequencing by Services market, 2018 - 2030 (USD Million)
  • Fig. 48 Global sequencing by Instruments/Systems/Softwares market, 2018 - 2030 (USD Million)
  • Fig. 49 Global sequencing by Consumables & Reagents market, 2018 - 2030 (USD Million)
  • Fig. 50 Global sequencing by NGS-based Services market, 2018 - 2030 (USD Million)
  • Fig. 51 Global sequencing by Core Genomics Services market, 2018 - 2030 (USD Million)
  • Fig. 52 Global sequencing by Biomarker Translation Services market, 2018 - 2030 (USD Million)
  • Fig. 53 Global sequencing by Computational Services market, 2018 - 2030 (USD Million)
  • Fig. 54 Global sequencing by Others market, 2018 - 2030 (USD Million)
  • Fig. 55 Global sequencing by Pharmaceutical and Biotechnology Companies market, 2018 - 2030 (USD Million)
  • Fig. 56 Global sequencing by Hospitals and Clinics market, 2018 - 2030 (USD Million)
  • Fig. 57 Global sequencing by Academic and Government Institutes market, 2018 - 2030 (USD Million)
  • Fig. 58 Global sequencing by Clinical Research market, 2018 - 2030 (USD Million)
  • Fig. 59 Global sequencing by Other End-uses market, 2018 - 2030 (USD Million)
  • Fig. 60 Regional marketplace: Key takeaways
  • Fig. 61 Regional marketplace: Key takeaways
  • Fig. 62 North America genomics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 63 U.S. key country dynamics
  • Fig. 64 U.S. genomics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 65 Canada key country dynamics
  • Fig. 66 Canada genomics market, 2018 - 2030 (USD Million)
  • Fig. 67 Europe genomics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 68 UK key country dynamics
  • Fig. 69 UK genomics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 70 Germany key country dynamics
  • Fig. 71 Germany genomics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 72 France key country dynamics
  • Fig. 73 France genomics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 74 Italy key country dynamics
  • Fig. 75 Italy genomics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 76 Spain key country dynamics
  • Fig. 77 Spain genomics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 78 Denmark key country dynamics
  • Fig. 79 Denmark genomics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 80 Sweden key country dynamics
  • Fig. 81 Sweden genomics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 82 Norway key country dynamics
  • Fig. 83 Norway genomics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 84 Asia-Pacific genomics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 85 Japan key country dynamics
  • Fig. 86 Japan genomics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 87 China key country dynamics
  • Fig. 88 China genomics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 89 India key country dynamics
  • Fig. 90 India genomics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 91 Australia key country dynamics
  • Fig. 92 Australia genomics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 93 Thailand key country dynamics
  • Fig. 94 Thailand genomics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 95 South Korea key country dynamics
  • Fig. 96 South Korea genomics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 97 Latin America genomics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 98 Brazil key country dynamics
  • Fig. 99 Brazil genomics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 100 Mexico key country dynamics
  • Fig. 101 Mexico genomics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 102 Argentina key country dynamics
  • Fig. 103 Argentina genomics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 104 MEA genomics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 105 South Africa key country dynamics
  • Fig. 106 South Africa genomics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 107 Saudi Arabia key country dynamics
  • Fig. 108 Saudi Arabia genomics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 109 UAE key country dynamics
  • Fig. 110 UAE genomics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 111 Kuwait key country dynamics
  • Fig. 112 Kuwait genomics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 113 Key company categorization
  • Fig. 114 Company market positioning
  • Fig. 115 Market participant categorization
  • Fig. 116 Strategy framework